Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Drake

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
European Journal of Endocrinology|November 6, 2008
Treatment of Nelson's syndrome with temozolomideV J Moyes, G Alusi, H I Sabin, et al.
Hormone Research|August 18, 2006
Growth hormone deficiency and replacement in patients with treated Cushing's Disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral densityA Colson, A M Brooke, D Walker, et al.
Clinical Endocrinology|August 25, 2005
Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacementT T Chung, W M Drake, J Evanson, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 2012
Effective combination treatment with cabergoline and low-dose pegvisomant in active acromegaly: a prospective clinical trialC E Higham, A B Atkinson, S Aylwin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2006
Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegalyA N Paisley, C J O'Callaghan, K C Lewandowski, et al.
Clinical Endocrinology|December 31, 2009
d3-GHR genotype does not explain heterogeneity in GH responsiveness in hypopituitary adultsV J Moyes, D M Walker, S Owusu-Antwi, et al.
British Journal of Cancer|July 18, 2013
Sequelae and survivorship in patients treated with (131)I-MIBG therapyW C C Sze, A B Grossman, I Goddard, et al.
Clinical Endocrinology|March 14, 1998
Metastatic parathyroid carcinoma in the MEN2A syndromeP J Jenkins, M A Satta, M Simmgen, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 1998
Optimizing growth hormone replacement therapy by dose titration in hypopituitary adultsW M Drake, D Coyte, C Camacho-Hübner, et al.
QJM : Monthly Journal of the Association of Physicians|February 10, 2017
Clinical outcomes following unilateral adrenalectomy in patients with primary aldosteronismM J Hannon, W C Sze, R Carpenter, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
European Journal of Endocrinology|November 6, 2008
Treatment of Nelson's syndrome with temozolomideV J Moyes, G Alusi, H I Sabin, et al.
Hormone Research|August 18, 2006
Growth hormone deficiency and replacement in patients with treated Cushing's Disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral densityA Colson, A M Brooke, D Walker, et al.
Clinical Endocrinology|August 25, 2005
Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacementT T Chung, W M Drake, J Evanson, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 2012
Effective combination treatment with cabergoline and low-dose pegvisomant in active acromegaly: a prospective clinical trialC E Higham, A B Atkinson, S Aylwin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2006
Reductions of circulating matrix metalloproteinase 2 and vascular endothelial growth factor levels after treatment with pegvisomant in subjects with acromegalyA N Paisley, C J O'Callaghan, K C Lewandowski, et al.
Clinical Endocrinology|December 31, 2009
d3-GHR genotype does not explain heterogeneity in GH responsiveness in hypopituitary adultsV J Moyes, D M Walker, S Owusu-Antwi, et al.
British Journal of Cancer|July 18, 2013
Sequelae and survivorship in patients treated with (131)I-MIBG therapyW C C Sze, A B Grossman, I Goddard, et al.
Clinical Endocrinology|March 14, 1998
Metastatic parathyroid carcinoma in the MEN2A syndromeP J Jenkins, M A Satta, M Simmgen, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 1998
Optimizing growth hormone replacement therapy by dose titration in hypopituitary adultsW M Drake, D Coyte, C Camacho-Hübner, et al.
QJM : Monthly Journal of the Association of Physicians|February 10, 2017
Clinical outcomes following unilateral adrenalectomy in patients with primary aldosteronismM J Hannon, W C Sze, R Carpenter, et al.
Pageof 9